Resveratrol
Resveratrol affects cell-signaling pathways and may confound attempts to interpret an unapproved c-Met-active compound.
Recommendation: Avoid experimental longevity or nootropic stacks involving dihexa.
Peptide ·Insufficient evidence ·Reviewed May 2026
Dihexa is an angiotensin IV-derived peptidomimetic that potentiates hepatocyte growth factor signaling at c-Met in preclinical studies. It is not FDA-approved and has no adequate published human safety or efficacy trials. Because HGF/c-Met signaling is relevant to cancer biology, self-use is medically inappropriate.
The bottom line
Evidence rating insufficient. Most-documented uses: preclinical synaptogenesis research, hgf/c-met signaling tool compound, animal memory-model effects. 3 sources indexed (2010–2014), with 3 interaction records on file.
Core mechanism
Dihexa binds hepatocyte growth factor and appears to facilitate HGF-dependent c-Met activation, hippocampal spinogenesis, synaptogenesis, and memory effects in animal models. The same pathway supports cell growth, motility, and repair, and dysregulated c-Met signaling is implicated in malignancy. Preclinical potency does not establish safe nootropic dosing.2
Peptides are generally not reliably orally bioavailable unless a specific studied oral formulation is used. Human use of research-grade products is not appropriate.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Laboratory Research Reagent.
Research-market pricing is not a dosing recommendation; human use is not FDA-approved unless specifically stated. Updated 2026-06-04.
Dose: Protocol-specific only
Timing: Study protocol only
Not a supplement protocol.
Dose: No FDA-approved dose
Timing: Not applicable
Human safety and efficacy are not established.
Dose: Laboratory-specific concentration
Timing: Laboratory protocol only
Not for human administration.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Animal synaptogenesis findings do not prove human cognitive benefit.3
Evaluate neurologic, sleep, medication, and mood causes.
No human trials support self-treatment.
High pathway risk relative to evidence.
Preclinical HGF/c-Met data are not dementia treatment evidence.
Use medical evaluation for cognitive decline.
Resveratrol affects cell-signaling pathways and may confound attempts to interpret an unapproved c-Met-active compound.
Recommendation: Avoid experimental longevity or nootropic stacks involving dihexa.
Quercetin has kinase and inflammatory signaling effects that complicate safety interpretation with dihexa.
Recommendation: Avoid combining unapproved cell-signaling agents.
St. John's Wort can alter mood and drug metabolism, complicating neuropsychiatric monitoring.
Recommendation: Avoid combining with CNS-active research peptides.
Numbered references. Citations throughout the page link here.
HGF/Met pathway is important in cancer biology
Dihexa potentiated HGF/c-Met signaling
Angiotensin IV analogs improved memory models
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.